Manufacturer record
Oscar Remedies Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
16 batches manufactured by Oscar Remedies Pvt. Ltd (Haryana) were declared Not of Standard Quality between March 2019 and May 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
16 records linked to Oscar Remedies Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Dexamethasone Sodium Phosphate Injection IP 10 ml | V250909Mfg 2025-09 · Exp 2027-08 | The sample does not conform to the IP with respect to Assay of Dexamethasone Sodium Phosphate eq. to Dexamethasone Phosphate.Assay | DTL JaipurState lab | May 2026 |
| Amikacin Sulphate Injection I.P. | V251007CMfg 2025-10 · Exp 2027-09 | The sample does not conform to I.P. with respect to test for Particulate matter and Description.Description | CDL, KolkataCDSCO lab | Mar 2026 |
| Fluorometholone Ophthalmic Solution USP | E240423AMfg 2024-04 · Exp 2026-03 | Test for SterilitySterility | DTL, Bengaluru, KarnatakaState lab | Nov 2025 |
| Amikacin Sulphate Injection IP (Amised 100) | V250114AMfg 2025-01 · Exp 2026-12 | Test for SterilitySterility | DTL, Bengaluru, KarnatakaState lab | Oct 2025 |
| Osocip-D Eye/Ear drops Ciprofloxacin & Dexamethasone Eye/Ear drops IP | E240113AMfg 2024-01 · Exp 2025-12 | Content of Ciprofloxacin in the sample is more (i.e 943.33% of the labelled amount) than the permissible limits. 2. identification test for the presence of Dexamethasone Sodium Phosphate. 3. The sample gives high performance liquid chromatographic identification test for the presence of Dexamethasone. 4. The content of Dexamthasone in the sample is 0.078% W/V. 5. Name of the sample: Ciprofloxacin & Dexamethasone Eye/Ear drops IP 2022.Identification | FDA Lab , MumbaiCDSCO lab | Jun 2025 |
| Oscorcip-D Eye/Ear Drops | E24020AMfg 2024-02 · Exp 2026-01 | 1. The content of Ciprofloxacin in the sample is more (i.e 1023.33% of the labelled amount) than the permissible limits. 2. The sample does not give HPLC identification test for the presence of Dexamethasone sodium phosphate. 3. The sample gives HPLC identification test for the presence of Dexamethasone. 4. The content of Dexamethasone in the sample is 0.066% w/v 5 . Test for the sterility.Identification | FDA Lab , MumbaiCDSCO lab | Jun 2025 |
| Calamine Lotion IP | 2451Mfg 2024-07 · Exp 2026-06 | Content of zinc oxideOther | CDTL ChennaiCDSCO lab | Jun 2025 |
| Spironolacto ne Tablets IP | T- 2403993Mfg 2024-03 · Exp 2026-02 | Sample does not conform to IP specification for Spironolactone Tablets with respect to DissolutionDissolution | DTL ChennaiState lab | Jan 2025 |
| Clopidogrel Tablets IP (Clopirel-75) | T-2401753Mfg 2024-01 · Exp 2025-12 | DissolutionDissolution | CDL KolkataCDSCO lab | Nov 2024 |
| Meropenem Injection IP (ZENEM 1 g INJECTION) | B240720DMfg 2024-07 · Exp 2026-06 | Particulate matter and Content of SodiumParticulate matter | RDTL ChandigarhCDSCO lab | Oct 2024 |
| Fexofenadine Hydrochloride Tablets I.P. | T-2403971Mfg 2023-03 · Exp 2026-02 | Dissolution of Fexofenadine Hydrochloride.Dissolution | RDTL GuwahatiCDSCO lab | Oct 2024 |
| Fexofenadine Hydrochloride Tablets IP | T-2403971Mfg 2024-03 · Exp 2026-02 | Uniformity of Weight and DissolutionDissolution | RDTL GuwahatiCDSCO lab | Sep 2024 |
| Ovit Cee Tablets (Ascorbic Acid Tablets IP ) | T-2306-08Mfg 2023-06 · Exp 2024-11 | Assay of 'Ascorbic Acid' and DescriptionAssay | CDL KolkataCDSCO lab | Dec 2023 |
| MEROXIA Nano Injection 1 gm (Meropenem Injection I.P.) | D220162Mfg 2022-01 · Exp 2023-12 | Assay of Meropenem & Content of SodiumAssay | CDL KolkataCDSCO lab | Mar 2023 |
| Prednisolone Acetate and Moxifloxacin Ophthalmic Suspension(M- Floxin-P Eye Drops) | O-066Mfg 2018-04 · Exp 2020-03 | Particle size and Assay of Predisolone AcetateAssay | RDTL ChandigarhState lab | Jul 2019 |
| CEFUROXIME AXETIL TABLETS I.P. (AXTUM-500) | BT-1804-06Mfg 2018-04 · Exp 2020-03 | DissolutionDissolution | RDTL GuwahatiState lab | Mar 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.